ABBV vs CVS
By Alex · Tickerpine
AbbVie Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | CVS |
|---|---|---|
| Price | $285.64 | $93.47 |
| Market cap | $504.76B | $119.55B |
| P/E ratio | 80.5 | 24.6 |
| ROE | — | 6.21% |
| Profit margin | 9.80% | 1.18% |
| Revenue growth | 10.20% | 7.10% |
| Dividend yield | 2.42% | 2.85% |
| Beta | 0.23 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs CVS in plain English
- ABBV is the bigger company — about 4.2× the market cap of CVS.
- CVS is cheaper on earnings (P/E 24.6 vs 80.5).
- ABBV is growing revenue faster (10% vs 7%).
- CVS has the higher dividend yield (2.85% vs 2.42%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.